AIM IMMUNOTECH INC. Other Receivables, Net, Current
AIM IMMUNOTECH INC. (AIM) had Other Receivables, Net, Current of $19.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2025-05-15
- 2025-03-31: Other Receivables, Net, Current $19.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2025-03-31 | $19.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |